Translated automatically – community improvements welcome.
Zaleplon
Zaleplon is a short-acting sedative from the pyrazolopyrimidine group, primarily used for the treatment of sleep disorders. It acts as an agonist at the GABA-A receptor, thereby enhancing the inhibitory effect of the neurotransmitter GABA. Due to its short half-life, it is preferred for sleep initiation. The risk of dependence and side effects is moderate, especially with prolonged use.
Mechanism of Action
- GABA-A agonist
Names / Identifiers
IUPAC: Zaleplon
Mechanism of Action
Zaleplon wirkt als ein selektiver Agonist an den GABA-A-Rezeptoren, was zu einer verstärkten Hemmung der neuronalen Aktivität führt und somit schlaffördernde Effekte erzeugt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Pregnancy
- Breastfeeding
- Severe respiratory diseases
Known Risks
- medium
- Zaleplon kann zu Abhängigkeit führen und hat potenzielle Wechselwirkungen mit anderen Substanzen.
Safer Use
- Start at a low dose.
- Avoid alcohol and other sedatives.
- Do not use longer than recommended.
Harm reduction tips do not replace medical advice.
Known Interactions
- Alcohol
- Benzodiazepines
- Opioids
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.